文献速递技术与安全US

低强度治疗性超声作用于人胰岛细胞后基因表达分析

Analyzing Gene Expression After Administration of Low-Intensity Therapeutic Ultrasound in Human Islet Cells.
PubMed 文献 · J Ultrasound Med · 2024-02-27

研究将800 kHz、0.5 W/cm²超声以100%占空比连续5分钟作用于供体人胰岛细胞,经1小时孵育后用RT-qPCR检测胰岛素、胰高血糖素、胰淀素和免疫球蛋白结合蛋白基因表达;结果显示所测基因均未出现统计学显著上调,所用超声参数似乎未显著影响所测基因表达。

要点

  • 800 kHz、0.5 W/cm²连续5分钟超声作用于人胰岛细胞后,所测基因均无统计学显著上调。
  • 胰岛素基因倍数变化1.15(P=.5692),胰高血糖素基因1.60(P=.2231)。
  • 胰淀素基因P=.2863、免疫球蛋白结合蛋白基因倍数变化2.68(P=.3907),均未达统计学显著。

核心结论

  • 所提出的超声治疗参数似乎未显著影响所测任何基因的表达。

研究设计与样本

  • 体外研究,将800 kHz、强度0.5 W/cm²超声以100%占空比连续5分钟作用于供体人胰岛细胞,孵育1小时后行RT-qPCR检测基因表达;9例供体人胰岛用于评估胰岛素和胰高血糖素分泌,8例样本用于胰淀素和免疫球蛋白结合蛋白;以高糖和毒胡萝卜素处理的胰岛作为阳性对照,采用台盼蓝排斥试验检测细胞活力。

诊断标准与关键数值

  • 倍数变化(FC)用于分析超声刺激对供体胰岛细胞基因表达的影响;胰岛素基因FC=1.15(P=.5692),胰高血糖素基因FC=1.60(P=.2231),胰淀素基因P=.2863,免疫球蛋白结合蛋白基因FC=2.68(P=.3907),均未达统计学显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Diabetes mellitus is a complex heterogenous metabolic disease that significantly affects the world population. Although many treatments exist, including medications such as metformin, sulfonylureas, and glucagon-like peptide-1 (GLP) receptor agonist, there is growing interest in finding alternative methods to noninvasively treat this disease. It has been previously shown that low-intensity ultrasound stimulation of pancreatic β-cells in mice can elicit insulin secretion as a potential treatment for this disease. This is desirable as therapeutic ultrasound has the ability to induce bioeffects while selectively focusing deep within tissues, allowing for modulation of hormone secretion in the pancreas to mitigate insufficient levels of insulin.

METHODS: Exactly 800 kHz ultrasound with intensity 0.5 W/cm2 was administered 5 minutes continuously, that is, 100% duty cycle, to donor pancreatic human islets, followed by 1 hour incubation and RT-qPCR to assess the effect of ultrasound stimulation on gene expression. The genes were insulin (INS), glucagon (Glu), amylin (Amy), and binding immunoglobulin protein (BiP). Nine donor pancreatic human islets were used to assess insulin and glucagon secretion, while eight samples were used for amylin and BiP. Fold change (FC) was calculated to analyze the effect of ultrasound stimulation on the gene expression of the donor islet cells. High-glucose and thapsigargin-treated islets were utilized as positive controls. Cell viability testing was done using a Trypan Blue Exclusion Test.

RESULTS: Ultrasound stimulation did not cause a statistically significant upregulation in any of the tested genes (INS FC = 1.15, P-value = .5692; Glu FC = 1.60, P-value = .2231; Amy FC, P-value = .2863; BiP FC = 2.68, P-value = .3907).

CONCLUSIONS: The results of this study show that the proposed ultrasound treatment parameters do not appear to significantly affect gene expression of any gene tested.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Hill J, Messina J, Jeremic A, et al. Analyzing Gene Expression After Administration of Low-Intensity Therapeutic Ultrasound in Human Islet Cells. J Ultrasound Med. 2024. PMID: 38414281. doi:10.1002/jum.16441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。